Healthpeak Properties (NYSE:DOC) Cut to “In-Line” at Evercore

Evercore cut shares of Healthpeak Properties (NYSE:DOC) from an outperform rating to an in-line rating in a research report released on Monday, MarketBeat reports. Evercore currently has $21.00 price target on the real estate investment trust’s stock.

Several other research firms also recently commented on DOC. Morgan Stanley reduced their price objective on Healthpeak Properties from $21.00 to $18.00 and set an “overweight” rating on the stock in a report on Tuesday, April 28th. Citigroup reduced their price objective on Healthpeak Properties from $18.00 to $17.50 and set a “neutral” rating on the stock in a report on Wednesday, April 1st. Wells Fargo & Company restated a “positive” rating on shares of Healthpeak Properties in a report on Tuesday, February 3rd. Weiss Ratings upgraded Healthpeak Properties from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, May 8th. Finally, Argus downgraded Healthpeak Properties from a “buy” rating to a “hold” rating in a report on Thursday, February 5th. Four equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to MarketBeat, Healthpeak Properties has an average rating of “Hold” and an average target price of $18.75.

Healthpeak Properties Trading Down 1.1%

DOC opened at $19.56 on Monday. The stock’s fifty day moving average is $17.19 and its two-hundred day moving average is $17.19. The company has a market capitalization of $13.48 billion, a P/E ratio of 61.11, a PEG ratio of 2.73 and a beta of 1.00. Healthpeak Properties has a 52 week low of $15.70 and a 52 week high of $19.87. The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 1.15.

Healthpeak Properties (NYSE:DOC) last released its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 EPS for the quarter, topping the consensus estimate of $0.43 by $0.02. The company had revenue of $752.95 million for the quarter, compared to the consensus estimate of $694.59 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.Healthpeak Properties’s quarterly revenue was up 7.1% on a year-over-year basis. During the same period last year, the business posted $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Analysts forecast that Healthpeak Properties will post 1.74 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The firm also recently disclosed a monthly dividend, which will be paid on Friday, June 26th. Stockholders of record on Monday, June 15th will be given a $0.1017 dividend. The ex-dividend date of this dividend is Monday, June 15th. This represents a c) dividend on an annualized basis and a dividend yield of 6.2%. Healthpeak Properties’s dividend payout ratio (DPR) is presently 381.25%.

Insider Buying and Selling at Healthpeak Properties

In other news, insider Scott R. Bohn sold 10,989 shares of the firm’s stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total value of $213,736.05. Following the completion of the sale, the insider owned 7,636 shares of the company’s stock, valued at $148,520.20. This trade represents a 59.00% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.23% of the stock is owned by insiders.

Institutional Trading of Healthpeak Properties

A number of institutional investors have recently made changes to their positions in the business. State Street Corp boosted its position in shares of Healthpeak Properties by 1.8% in the 3rd quarter. State Street Corp now owns 49,498,109 shares of the real estate investment trust’s stock worth $947,889,000 after purchasing an additional 895,460 shares in the last quarter. JPMorgan Chase & Co. boosted its position in shares of Healthpeak Properties by 8.6% in the 4th quarter. JPMorgan Chase & Co. now owns 30,674,812 shares of the real estate investment trust’s stock worth $493,251,000 after purchasing an additional 2,438,278 shares in the last quarter. Fuller & Thaler Asset Management Inc. boosted its position in shares of Healthpeak Properties by 19.2% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust’s stock worth $476,744,000 after purchasing an additional 4,776,056 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Healthpeak Properties by 0.6% in the 4th quarter. Geode Capital Management LLC now owns 19,534,041 shares of the real estate investment trust’s stock worth $312,959,000 after purchasing an additional 123,274 shares in the last quarter. Finally, Invesco Ltd. boosted its position in shares of Healthpeak Properties by 9.9% in the 4th quarter. Invesco Ltd. now owns 18,298,776 shares of the real estate investment trust’s stock worth $294,244,000 after purchasing an additional 1,648,012 shares in the last quarter. Institutional investors and hedge funds own 93.57% of the company’s stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.